Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021Alize J Ferrari, Masayuki Teramoto, Robert Kaba Alhassan et al.|The Lancet|2024Cited by 4.4k
Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021Masayuki Teramoto, Robert Ancuceanu, Theo Vos et al.|The Lancet Public Health|2025Cited by 186
Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021Masayuki Teramoto, Salah Al Awaidy, Olugbenga Olusola Abiodun et al.|The Lancet Public Health|2024Cited by 125
(untitled)Awoke Misganaw, Mohsen Naghavi, Ally Walker et al.|Institutional Repository University of Antwerp (University of Antwerp)|2022Cited by 80
Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000–2018Emily Haeuser, Pankaj Bhardwaj, Audrey L. Serfes et al.|BMC Medicine|2022Cited by 56